17 studies found for:    Ustekinumab | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
Condition: Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Guselkumab;   Drug: Placebo for ustekinumab;   Drug: Placebo for guselkumab
2 Recruiting Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
Condition: Psoriasis
Interventions: Biological: Ustekinumab;   Biological: Abatacept;   Drug: Placebo for Ustekinumab;   Drug: Placebo for Abatecept
3 Recruiting Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Ustekinumab;   Other: Placebo
4 Not yet recruiting Exploratory Study on Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: INGAP Peptide, Ustekinumab
5 Not yet recruiting Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D
Condition: Type 1 Diabetes
Intervention: Drug: Ustekinumab
6 Recruiting Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency
Conditions: CVID;   Enteropathy;   Chronic Diarrhea;   Maldigestion;   Malabsorption
Intervention: Biological: Ustekinumab
7 Recruiting Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
Conditions: Psoriasis;   Cardiovascular Disease
Interventions: Drug: Ustekinumab;   Drug: Placebo
8 Unknown  A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Conditions: Scalp Psoriasis;   Plaque Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo
9 Recruiting Swiss Dermatology Network of Targeted Therapies (SDNTT)
Condition: Psoriasis
Interventions: Biological: Adalimumab;   Biological: Etanercept;   Biological: Infliximab;   Biological: Ustekinumab;   Drug: Cyclosporine A;   Drug: Fumaric acids;   Drug: Methotrexate;   Drug: Other anti-psoriatic systemic treatments
10 Recruiting The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment
Condition: Psoriasis
Intervention: Drug: Ustekinumab
11 Recruiting Stelara Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
Conditions: Psoriasis;   Pregnancy
Intervention:
12 Recruiting BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab
Condition: Psoriasis
Interventions: Drug: BI 655066;   Drug: Ustekinumab
13 Recruiting Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
Condition: Psoriasis
Interventions: Drug: etanercept;   Drug: ustekinumab;   Drug: cyclosporine
14 Recruiting PsoBest - The German Psoriasis Registry
Conditions: Psoriasis;   Psoriatic-arthritis
Intervention:
15 Recruiting Spanish Registry of Systemic Treatments in Psoriasis
Condition: Psoriasis
Intervention:
16 Recruiting Clinical Assessment and Psychosocial Impact of Psoriasis
Condition: Psoriasis
Intervention:
17 Recruiting Evaluation of Vitamin D Levels in Psoriasis Patients
Condition: Psoriasis
Interventions: Other: Topical Therapy;   Other: Phototherapy and Systemic Therapy;   Other: Biologic Therapy

Indicates status has not been verified in more than two years